Zinc oxide nanoparticles mitigate insulin resistance in a D-galactose-induced C57BL/6 mouse model.
A correction to this paper has been published: the notice, 42255446, from Europe PMC.
Overview
Abstract
D-galactose promotes insulin resistance (IR) and neurodegeneration through hyperglycemia, advanced glycation end products (AGEs), oxidative stress, amyloid-β accumulation, and disruption of the insulin signalling pathway, leading to neuroinflammation and neuroapoptosis. The purpose of this study was to investigate the insulin signalling pathway and efficacy of ZnO nanoparticles (ZnO NPs) in alleviating brain IR and neurodegeneration via regulating IRS/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE152539, at NCBI GEO; found in the text, “Transcriptomic data collection and analysis…”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Transcriptomic data collection and analysis…”
Data availability statement
The original contributions presented in the study are included in the article/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 2 authors, 5 keywords, 14 MeSH terms, 90 references, 1 integrity notice.
Cite
This paper
Ramasubbu, K., & V, D. R. (2026). Zinc oxide nanoparticles mitigate insulin resistance in a D-galactose-induced C57BL/
BibTeX
@article{ramasubbu2026zi
author = {Ramasubbu, Kanagavalli and V, Devi Rajeswari},
title = {{Zinc oxide nanoparticles mitigate insulin resistance in a D-galactose-induced C57BL/
journal = {Frontiers in endocrinology},
year = {2026},
month = may,
volume = {17},
pages = {1819985},
publisher = {Frontiers Media SA},
issn = {1664-2392},
doi = {10.3389/
url = {https://
pmid = {42255438},
pmcid = {PMC13237717}
}
RIS
TY - JOUR
AU - Ramasubbu, Kanagavalli
AU - V, Devi Rajeswari
TI - Zinc oxide nanoparticles mitigate insulin resistance in a D-galactose-induced C57BL/
T2 - Frontiers in endocrinology
J2 - Front Endocrinol (Lausanne)
PY - 2026
DA - 2026/
VL - 17
SP - 1819985
SN - 1664-2392
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Zinc oxide nanoparticles mitigate insulin resistance in a D-galactose-induced C57BL/
"container-title": "Frontiers in endocrinology",
"author": [
{
"family": "Ramasubbu",
"given": "Kanagavalli"
},
{
"family": "V",
"given": "Devi Rajeswari"
}
],
"container-title-short":
"volume": "17",
"page": "1819985",
"DOI": "10.3389/
"PMID": "42255438",
"PMCID": "PMC13237717",
"ISSN": "1664-2392",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
12
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/genes17020195
- Region-Specific NRF2 Signaling in HIV-Associated Neurocognitive Disorders: A Transcriptomic and Computational Histology Study.Journal: GenesIn common: Alzheimer's / dementia, other condition, cellular / molecular, 1 reference
- [2] doi:10.3390/nu17243958
- From Microbiota to Metabolomics: How &
lt;i& gt;Corylus heterophylla& lt;/ i& gt; Fisch. Male Flower Extract Shields Mice from Cognitive Decline. Journal: NutrientsIn common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference - [3] doi:10.1038/s42003-024-06242-1
- Detecting the effect of genetic diversity on brain composition in an Alzheimer's disease mouse model.Journal: Communications biologyIn common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference
- [4] doi:10.1002/alz.71471 [code]
- How does type 2 diabetes modify the risk of Alzheimer's disease?Journal: Alzheimer's & dementia : the journal of the Alzheimer's AssociationIn common: Alzheimer's / dementia, other condition, cellular / molecular, 1 reference
- [5] doi:10.1021/envhealth.4c00175
- Disruption of Copper Redox Balance and Dysfunction under &
lt;i& gt;In Vivo& lt;/ i& gt; and & lt;i& gt;In Vitro& lt;/ i& gt; Alzheimer's Disease Models. Journal: Environment & health (Washington, D.C.)In common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference - [6] doi:10.1016/j.ebiom.2025.105791
- Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis.Journal: EBioMedicineIn common: other condition, mouse, cellular / molecular, 1 reference
- [7] doi:10.7717/peerj.15122
- The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy.Journal: PeerJIn common: other condition, mouse, cellular / molecular, 1 reference
- [8] doi:10.34133/csbj.0085 [code]
- A Systems-Level Transcriptomic Framework Identifies Shared Cellular Hubs in Osteoarthritis and Alzheimer's Disease.Journal: Computational and structural biotechnology journalIn common: Alzheimer's / dementia, cellular / molecular, 1 reference
- [9] doi:10.14336/ad.2023.0707 [code]
- Alzheimer Disease Pathology and Neurodegeneration in Midlife Obesity: A Pilot Study.Journal: Aging and diseaseIn common: Alzheimer's / dementia, other condition, 1 reference
- [10] doi:10.1080/19336934.2025.2558387 [code]
- VacQuant: a tool to quantify neurodegeneration and associated vacuolation in brain tissue.Journal: FlyIn common: Alzheimer's / dementia, other condition, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
